[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Orphan Drug Market to See Huge Growth to 2022, According to New Kuick Research Report Now Available at MarketPublishers.com

16 Dec 2016 • by Natalie Aster

LONDON – Worldwide, there are currently over 300 marketed orphan designated drugs and close to 800 drugs in clinical research. 

The orphan drug market has witnessed an exponential growth over the past twenty years. There has been a paradigm shift in the pharmaceutical or biopharmaceutical marketplace with focus on R&D for unmet clinical/medical needs, pouring money into the development of drug products to treat rare diseases thus targeting a limited number of patients. The global market for orphan drugs is gaining traction owing to tax abatements, waived FDA fees, grants, decreased timelines for clinical research and a greater chance of regulatory approval. Other factors like the expirations of patents, drying pipelines and generic completions are also contributing to the market growth.

While the orphan drug market is currently mostly restricted to the USA and Europe, pharmacos are poised to begin tapping into Asia’s market which has a large number of untreated rare medical conditions. Hence, the global orphan drug market cannot stop but grow in the offing.

New research publication “Global Orphan Drug Clinical Pipeline Insight 2022” by Kuick Research provides qualitative, true insights into various non-clinical and clinical aspects related to continuous clinical trials of 808 orphan designated drug products from pole to pole.

The report provides a detailed overview of the marketplace and reviews orphan designated drugs in clinical development phase.

The study casts light on global orphan drug designation criteria across various key countries. It looks at the global orphan drug clinical pipeline, categorised based on company, indication and phase. Marketed orphan drug clinical insights are presented by company, phase and indication. An overview of discontinued and suspended orphan drug products in clinical development is given as well. The report examines the competitive landscape in the marketplace and gives details about the 20 leading market players. Furthermore, future market prospects are also outlined in the study.

More new insightful reports by Kuick Research are offered at this page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest